reSee.it Video Transcript AI Summary
The discussion centers on a Dutch civil litigation in which Bill Gates, Albert Bourla, and Marc Rutemp (Marc Rutza) are named as individual defendants in cases linked to “Project COVID” and broad pandemic preparedness efforts years before the 2020 pandemic.
Key facts asserted:
- The defendants are plaintiffs in civil tort litigation filed in the Netherlands around 2023. Two cases exist: an older 2023 case and a second case involving additional plaintiffs. The Dutch approach allows individuals to be named as defendants in civil tort actions.
- Gates and Bourla (and Rutza) have appeared as defendants; Gates attempted to avoid jurisdiction, but the Amsterdam court ruled that Gates and Bourla, as individuals, respond to the case. They have not appeared in court personally, but their lawyers appear on their behalf.
- On March 9, an appeal hearing occurred in Amsterdam at the Court of Appeals, with extensive public attendance (about 60 journalists, podcasters, and plaintiffs). The hearing was described as explosive; a single attorney, Peter Stassen, presented a long argument as co-counsel had been imprisoned and disbarred, leaving one attorney on a tight budget. A video of the proceedings and a standout speech went viral.
- The plaintiffs allege the defendants conspired to create “Project COVID” and a “pandemic preparedness racket” years prior to 2020. The core claim is that Gates, Bourla, Rutza, along with others, collaborated with private NGOs, the military, NATO, and DOD through a DARPA-linked pandemic program to identify pandemic potential viruses and to develop vaccines and therapeutics within sixty days, with funding from the DOD.
- Evidence cited includes a 2017 AstraZeneca tape in which a key AstraZeneca executive states that DARPA approached them in 2017 to join a consortium to identify pandemic viruses and deliver vaccines within sixty days; the response was, “I thought it was science fiction.” The tape is part of an evidence package showing pre-2020 planning.
- February 4, 2020 is highlighted as a crucial date: a telephone call from DARPA indicating COVID was declared a national security threat, followed by retroactive emergency declarations around March 2020. A February 4, 2020 conference was scheduled, with widespread communications among government, military, HHS, and CDC; the aim was to secure liability protection for pharmaceutical countermeasures during a declared emergency.
- The defense includes the assertion that the public-private partnership extended to many companies (including 300 others) that joined the consortium, with U.S. and European regulatory synchronization through mutual recognition agreements.
- The alleged motives are primarily framed as profits and control, with references to a long-standing history of military involvement in vaccine development and public health measures, including the PREP Act in the U.S. and parallel European countermeasures frameworks that waive liability and regulatory requirements during declared emergencies. The PREP Act’s role — especially in the U.S. — is discussed as shielding manufacturers from liability, with European frameworks described as allowing similar protections through contracts and synchronized countermeasures legislation.
- Expert testimonies: five experts have provided evidence supporting foreknowledge and intentional deception by government health officials and the named defendants. Sasha Ladopova and Catherine Watt contributed written testimonies; Ladopova references foreknowledge by health regulators, and the broader regulatory harmonization across EMA and FDA.
- Francis Boyle, a professor known for work on bioweapons law, testified that the vaccines/metas could be viewed as bioweapons; he died three weeks after agreeing to testify.
- Injuries to plaintiffs: in the initial case, seven injured plaintiffs with one death; the second case added three more plaintiffs. Injuries cited include cardiovascular inflammation, autoimmune conditions, and cancer; plaintiffs contend their lives were destroyed by the countermeasures, while regulators and manufacturers allegedly denied injuries and deaths.
What happens next:
- An October 22 hearing in the lower court in Lewarden (The Netherlands) is planned, with a public in-person event and a press conference.
- The appeal on the second case seeks to have expert witnesses heard under oath; the prior lower court denied this, and the higher court’s decision is anticipated (with expectations of denial, according to the interview).
- The campaign invites public interest and financial support; the foundation in the Netherlands funds the case, and the English-language YouTube channel is available for updates and evidence.
Contact points for following the case include Sasha Ladopova’s Substack and the Dutch foundation’s YouTube channel and materials.